New patent for Loxo Oncology drug RETEVMO

October 22, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for RETEVMO Retevmo is a drug marketed by Loxo Oncology Inc and is included in one NDA. It is available from one supplier. There are five…

The post New patent for Loxo Oncology drug RETEVMO appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.